AFC-HD AMS Life Science Co.,Ltd.【JP:2927】Income statement

Market cap

¥12.7B

P/E ratio

8.5x

AFC-HD Amus Life Science develops and sells health foods, cosmetics, and pharmaceuticals to consumers and medical institutions across multiple channels.

Summary Financials Dividends History Segments Ownership Workforce

Income statement Balance sheet Cash flow Other

	2011/08	2012/08	2013/08	2014/08	2015/08	2016/08	2017/08	2018/08	2019/08	2020/08	2021/08	2022/08	2023/08	2024/08	2025/08
Revenue	14,654	14,795	14,366	13,728	14,415	14,631	15,142	15,796	16,253	15,819	22,368	22,997	25,579	30,185	32,655
Revenue growth (%)	-
Cost of revenue	-	-	-	9,616	10,154	10,241	10,534	11,203	11,732	11,265	15,503	14,418	16,256	19,694	21,394
Gross profit	-	-	-	4,112	4,261	4,390	4,608	4,593	4,521	4,555	6,865	8,579	9,323	10,492	11,261
Gross margin (%)	-	-	-
Operating margin (%)	-	-	-
Operating expenses	-	-	-	3,548	3,310	3,499	3,539	3,569	3,540	3,461	4,620	7,568	7,687	8,576	8,852
Operating income	-	-	-	565	951	891	1,069	1,023	981	1,094	2,245	1,011	1,636	1,916	2,410
Income before tax	996	674	818	508	892	812	1,040	982	1,015	1,100	2,162	1,343	1,654	1,921	2,444
Pretax margin (%)	6.8	4.6	5.7	3.7	6.2	5.6	6.9	6.2	6.2	7	9.7	5.8	6.5	6.4	7.5
Provision for income taxes	-	-	-	211	356	269	171	249	308	328	662	498	439	665	732
Effective tax rate (%)	-	-	-
Net income	490	569	572	283	606	490	466	737	783	677	1,496	738	1,107	1,252	1,469
Net income margin (%)
Earnings per share	41.13	47.74	48.14	23.82	50.64	40.47	38.48	58.28	55.7	48.12	107.12	52.33	78.51	89.2	102.98
Diluted EPS	41.12	-	-	23.48	50	40.34	-	-	-	-	106.3	52.08	78.46	89.11	102.97
Dividend payout ratio (%)	-	-	-	-	-	-	-	-	-	-
Dividend per share	-	-	-	-	-	-	-	-	25	20	27.5	30	27.5	30	34
EBITDA	-	-	-
EBITDA margin (%)	-	-	-